Genetic Evidence of Serum Phosphate-Independent Functions of FGF-23 on Bone
Author(s) -
Despina Sitara,
Somi Kim,
Mohammed S. Razzaque,
Clemens Bergwitz,
Takashi Taguchi,
Christiane Schüler,
Reinhold G. Erben,
Beate Lanske
Publication year - 2008
Publication title -
plos genetics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.587
H-Index - 233
eISSN - 1553-7404
pISSN - 1553-7390
DOI - 10.1371/journal.pgen.1000154
Subject(s) - fibroblast growth factor 23 , biology , fibroblast growth factor , hyperphosphatemia , hypophosphatemia , endocrinology , homeostasis , medicine , mutant , microbiology and biotechnology , parathyroid hormone , gene , genetics , calcium , receptor , kidney disease
Maintenance of physiologic phosphate balance is of crucial biological importance, as it is fundamental to cellular function, energy metabolism, and skeletal mineralization. Fibroblast growth factor-23 (FGF-23) is a master regulator of phosphate homeostasis, but the molecular mechanism of such regulation is not yet completely understood. Targeted disruption of the Fgf-23 gene in mice ( Fgf-23 −/− ) elicits hyperphosphatemia, and an increase in renal sodium/phosphate co-transporter 2a (NaPi2a) protein abundance. To elucidate the pathophysiological role of augmented renal proximal tubular expression of NaPi2a in Fgf-23 −/− mice and to examine serum phosphate–independent functions of Fgf23 in bone, we generated a new mouse line deficient in both Fgf-23 and NaPi2a genes, and determined the effect of genomic ablation of NaPi2a from Fgf-23 −/− mice on phosphate homeostasis and skeletal mineralization. Fgf-23 −/− /NaPi2a −/− double mutant mice are viable and exhibit normal physical activities when compared to Fgf-23 −/− animals. Biochemical analyses show that ablation of NaPi2a from Fgf-23 −/− mice reversed hyperphosphatemia to hypophosphatemia by 6 weeks of age. Surprisingly, despite the complete reversal of serum phosphate levels in Fgf-23 −/− /NaPi2a −/− , their skeletal phenotype still resembles the one of Fgf23 −/− animals. The results of this study provide the first genetic evidence of an in vivo pathologic role of NaPi2a in regulating abnormal phosphate homeostasis in Fgf-23 −/− mice by deletion of both NaPi2a and Fgf-23 genes in the same animal. The persistence of the skeletal anomalies in double mutants suggests that Fgf-23 affects bone mineralization independently of systemic phosphate homeostasis. Finally, our data support (1) that regulation of phosphate homeostasis is a systemic effect of Fgf-23, while (2) skeletal mineralization and chondrocyte differentiation appear to be effects of Fgf-23 that are independent of phosphate homeostasis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom